ESC 365 - The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure

Back

ESC Professional Premium Access

The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study

Session: Pharmacotherapy in myocardial infarction

Topic: Beta-Blockers

Speaker: Doctor A. Halili (Copenhagen, DK)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Andrim Halili

Zealand university hospital, Copenhagen (Denmark)

0 follower

5 more presentations in this session

Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction

Speaker: Assistant Professor J. Choe (Pusan, KR)

Access

Abstract

Slides

Influence of cholesterol levels on NSAID-associated risks after myocardial infarction: a nationwide population-based cohort study

Speaker: Mr M. Basem Abdallah (Aarhus, DK)

Empagliflozin in patients with myocardial infarction: an updated meta-analysis

Speaker: Doctor M. Abouzid (Poznan, PL)

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry

Speaker: Doctor P. Paolisso (Milan, IT)

Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study

Speaker: Doctor A. Aimo (Pisa, IT)

Access

Abstract

Slides

Access the full session

Pharmacotherapy in myocardial infarction

Speakers: Doctor A. Halili, Assistant Professor J. Choe, Mr M. Basem Abdallah, Doctor M. Abouzid, Doctor P. Paolisso...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources